pCMV-Myc-XPLN-L269E Citations (1)

Originally described in: XPLN is an endogenous inhibitor of mTORC2.
Khanna N, Fang Y, Yoon MS, Chen J Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):15979-84. doi: 10.1073/pnas.1310434110. Epub 2013 Sep 16. PubMed Journal

---

Articles Citing pCMV-Myc-XPLN-L269E

Articles
ARHGEF3 Regulates Skeletal Muscle Regeneration and Strength through Autophagy. You JS, Singh N, Reyes-Ordonez A, Khanna N, Bao Z, Zhao H, Chen J. Cell Rep. 2021 Jan 5;34(1):108594. doi: 10.1016/j.celrep.2020.108594. PubMed

If you have published an article using this material, please email us at to have your article added to this page.